Annual Current Assets
$97.51 M
-$55.36 M-36.21%
December 31, 2023
Summary
- As of February 26, 2025, RLMD annual total current assets is $97.51 million, with the most recent change of -$55.36 million (-36.21%) on December 31, 2023.
- During the last 3 years, RLMD annual current assets has fallen by -$20.56 million (-17.42%).
- RLMD annual current assets is now -56.33% below its all-time high of $223.30 million, reached on December 31, 2021.
Performance
RLMD Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$55.70 M
-$15.27 M-21.52%
September 30, 2024
Summary
- As of February 26, 2025, RLMD quarterly total current assets is $55.70 million, with the most recent change of -$15.27 million (-21.52%) on September 30, 2024.
- Over the past year, RLMD quarterly current assets has dropped by -$28.66 million (-33.97%).
- RLMD quarterly current assets is now -75.33% below its all-time high of $225.78 million, reached on March 31, 2022.
Performance
RLMD Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
RLMD Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -36.2% | -34.0% |
3 y3 years | -17.4% | -38.7% |
5 y5 years | +876.6% | +571.2% |
RLMD Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -56.3% | at low | -75.3% | at low |
5 y | 5-year | -56.3% | at low | -75.3% | +571.2% |
alltime | all time | -56.3% | >+9999.0% | -75.3% | >+9999.0% |
Relmada Therapeutics Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $55.70 M(-21.5%) |
Jun 2024 | - | $70.97 M(-15.9%) |
Mar 2024 | - | $84.36 M(-13.5%) |
Dec 2023 | $43.10 K(+23.5%) | $97.51 M(-10.6%) |
Sep 2023 | - | $109.10 M(-10.6%) |
Jun 2023 | - | $122.00 M(-10.0%) |
Mar 2023 | - | $135.53 M(-11.3%) |
Dec 2022 | $34.90 K(+23.3%) | $152.87 M(-18.3%) |
Sep 2022 | - | $187.11 M(-13.3%) |
Jun 2022 | - | $215.74 M(-4.4%) |
Mar 2022 | - | $225.78 M(+1.1%) |
Dec 2021 | $28.30 K(-74.9%) | $223.30 M(+145.7%) |
Sep 2021 | - | $90.89 M(-17.9%) |
Jun 2021 | - | $110.70 M(+6.7%) |
Mar 2021 | - | $103.78 M(-12.1%) |
Dec 2020 | $112.60 K(-42.5%) | $118.07 M(-5.9%) |
Sep 2020 | - | $125.47 M(-6.7%) |
Jun 2020 | - | $134.40 M(+16.6%) |
Mar 2020 | - | $115.25 M(+1288.8%) |
Dec 2019 | $195.80 K(-16.8%) | - |
Sep 2019 | - | $8.30 M(-16.9%) |
Jun 2019 | $235.40 K | $9.98 M(+328.5%) |
Mar 2019 | - | $2.33 M(-23.1%) |
Dec 2018 | - | $3.03 M(+138.7%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2018 | - | $1.27 M(-53.6%) |
Jun 2018 | $310.10 K(-14.3%) | $2.74 M(-38.9%) |
Mar 2018 | - | $4.48 M(-28.2%) |
Dec 2017 | - | $6.24 M(+18.6%) |
Sep 2017 | - | $5.27 M(+112.7%) |
Jun 2017 | $362.00 K(-61.7%) | $2.47 M(-23.7%) |
Mar 2017 | - | $3.24 M(-38.8%) |
Dec 2016 | - | $5.30 M(-24.0%) |
Sep 2016 | - | $6.97 M(-25.0%) |
Jun 2016 | $945.70 K(+122.7%) | $9.30 M(-21.0%) |
Mar 2016 | - | $11.78 M(-24.8%) |
Dec 2015 | - | $15.66 M(-21.9%) |
Sep 2015 | - | $20.05 M(-16.3%) |
Jun 2015 | $424.70 K(+1839.3%) | $23.97 M(-13.8%) |
Mar 2015 | - | $27.81 M(-15.1%) |
Dec 2014 | - | $32.76 M(+17.8%) |
Sep 2014 | - | $27.82 M(>+9900.0%) |
Jun 2014 | $21.90 K(+1360.0%) | - |
Feb 2014 | - | $8800.00(-19.3%) |
Nov 2013 | - | $10.90 K(-41.1%) |
Aug 2013 | $1500.00(>+9900.0%) | $18.50 K(+516.7%) |
May 2013 | - | $3000.00(-70.6%) |
Feb 2013 | - | $10.20 K(-44.6%) |
Aug 2012 | $0.00 | $18.40 K |
FAQ
- What is Relmada Therapeutics annual total current assets?
- What is the all time high annual current assets for Relmada Therapeutics?
- What is Relmada Therapeutics annual current assets year-on-year change?
- What is Relmada Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Relmada Therapeutics?
- What is Relmada Therapeutics quarterly current assets year-on-year change?
What is Relmada Therapeutics annual total current assets?
The current annual current assets of RLMD is $97.51 M
What is the all time high annual current assets for Relmada Therapeutics?
Relmada Therapeutics all-time high annual total current assets is $223.30 M
What is Relmada Therapeutics annual current assets year-on-year change?
Over the past year, RLMD annual total current assets has changed by -$55.36 M (-36.21%)
What is Relmada Therapeutics quarterly total current assets?
The current quarterly current assets of RLMD is $55.70 M
What is the all time high quarterly current assets for Relmada Therapeutics?
Relmada Therapeutics all-time high quarterly total current assets is $225.78 M
What is Relmada Therapeutics quarterly current assets year-on-year change?
Over the past year, RLMD quarterly total current assets has changed by -$28.66 M (-33.97%)